more

Inspire Medical Systems (INSP)

(Delayed Data from NYSE)

$190.71 USD

-4.33 (-2.22%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $190.90 +0.19 (0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth B Momentum B VGM

Industry Rank:

Top 30% (74 out of 250)

Industry: Medical Info Systems

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Inspire Medical (INSP) Hits 52-Week High: What's Aiding It?

by Zacks Equity Research Published on June 26,2023

Investors are optimistic about Inspire Medical's (INSP) global presence.

Inspire (INSP) Gets FDA Nod for Expanded Indication of AHI

by Zacks Equity Research Published on June 12,2023

The FDA approves Inspire's (INSP) application to expand the indication to include patients with AHI up to 100 events per hour.

Syneos Health (SYNH) Down 0.1% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research Published on June 09,2023

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Inspire (INSP) Up 6.3% Since Last Earnings Report?

by Zacks Equity Research Published on June 01,2023

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

INSPNegative Net Change

3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio

by Zacks Equity Research Published on May 22,2023

Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.

Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar?

by Zacks Equity Research Published on May 10,2023

Style Box ETF report for VTWO

Inspire Medical (INSP) Q1 Earnings & Revenues Top Estimates

by Zacks Equity Research Published on May 03,2023

Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the first quarter.

Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research Published on May 02,2023

Inspire (INSP) delivered earnings and revenue surprises of 24.29% and 6.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Hims & Hers Health, Inc. (HIMS) Surges 10.3%: Is This an Indication of Further Gains?

by Zacks Equity Research Published on April 19,2023

Hims & Hers Health, Inc. (HIMS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

What Makes Inspire (INSP) a New Buy Stock

by Zacks Equity Research Published on April 13,2023

Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

INSPNegative Net Change

Zacks Industry Outlook Highlights Inspire Medical Systems, Olink Holding and Health Catalyst

by Zacks Equity Research Published on April 05,2023

Inspire Medical Systems, Olink Holding and Health Catalyst have been highlighted in this Industry Outlook article.

medical

3 Medical Info Systems Stocks Countering Industry-wide Headwinds

by Urmimala Biswas Published on April 04,2023

Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Olink Holding (OLK) and Health Catalyst (HCAT) are expected to gain even as COVID-19 severity fades.